|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
0.01/0.56
|
企业价值
--
|
资产负债 |
每股账面净值
3.95
|
现金流量 |
现金流量率
--
|
损益表 |
收益
--
|
每股收益
--
|
同行比较
|
||||||||||||||||
|
报价延迟最少15分钟:2024/04/24 21:48 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions. |